Legal & General Group
PRTK

Legal & General Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Legal & General Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,978
Closed -$15K – 3718
2022
Q1 		$15K Buy
4,978
+247
+5% +$929 ﹤0.01% 3313
2021
Q4 		$21K Hold
4,731
– – ﹤0.01% 3270
2021
Q3 		$23K Hold
4,731
– – ﹤0.01% 3234
2021
Q2 		$32K Hold
4,731
– – ﹤0.01% 3119
2021
Q1 		$33K Sell
4,731
-295
-6% -$2.12K ﹤0.01% 2965
2020
Q4 		$31K Hold
5,026
– – ﹤0.01% 2946
2020
Q3 		$27K Sell
5,026
-1,593
-24% -$7.89K ﹤0.01% 2886
2020
Q2 		$35K Buy
6,619
+1,494
+29% +$6.64K ﹤0.01% 2833
2020
Q1 		$16K Sell
5,125
-729
-12% -$2.69K ﹤0.01% 3006
2019
Q4 		$24K Buy
5,854
+1,151
+24% +$3.99K ﹤0.01% 3136
2019
Q3 		$20K Hold
4,703
– – ﹤0.01% 3136
2019
Q2 		$19K Hold
4,703
– – ﹤0.01% 3223
2019
Q1 		$25K Hold
4,703
– – ﹤0.01% 3021
2018
Q4 		$24K Hold
4,703
– – ﹤0.01% 3011
2018
Q3 		$46K Hold
4,703
– – ﹤0.01% 2815
2018
Q2 		$48K Sell
4,703
-7
-0.1% -$79 ﹤0.01% 2771
2018
Q1 		$61K Sell
4,710
-1,179
-20% -$17.6K ﹤0.01% 2660
2017
Q4 		$106K Sell
5,889
-176
-3% -$3.67K ﹤0.01% 2553
2017
Q3 		$153K Buy
6,065
+200
+3% +$4.66K ﹤0.01% 2436
2017
Q2 		$144K Buy
5,865
+687
+13% +$15.2K ﹤0.01% 2428
2017
Q1 		$99K Hold
5,178
– – ﹤0.01% 2550
2016
Q4 		$79K Buy
5,178
+2,810
+119% +$36.5K ﹤0.01% 2701
2016
Q3 		$31K Hold
2,368
– – ﹤0.01% 2723
2016
Q2 		$32K Buy
+2,368
New +$34.9K ﹤0.01% 2702

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Legal & General Group's PRTK Position: Q2 2022 in Review

Legal & General Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 4,978 shares — an estimated $15K sold.

Legal & General Group first reported a position in PRTK in Q2 2016 and held it in 24 quarters. The position peaked at $153K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Legal & General Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 4,978 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $15K.
  • Legal & General Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2016 and held it in 24 quarters.
  • Legal & General Group's Paratek Pharmaceuticals, Inc. position peaked at $153K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.